These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 4514373)

  • 21. Bone metabolism and vitamin D levels in carbamazepine-treated patients.
    Verrotti A; Matricardi S; Manco R; Chiarelli F
    Epilepsia; 2006 Sep; 47(9):1586; author reply 1586-7. PubMed ID: 16981880
    [No Abstract]   [Full Text] [Related]  

  • 22. [The optimization of epilepsy therapy with finlepsin].
    Gromov SA; Khorshev SK; Mikhaĭlov VA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2000; 100(9):32-5. PubMed ID: 11026133
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Monotherapy in epilepsy: relations between clinical effects and plasma levels of the drug in patients treated only with carbamazepine].
    Monaco F; Riccio A; Gerna M; Morselli PL
    Acta Neurol (Napoli); 1975; 30(5):530-9. PubMed ID: 779411
    [No Abstract]   [Full Text] [Related]  

  • 24. [Tegretol in the treatment of epilepsy].
    Salomez JL
    Lille Med; 1979 Dec; 24(10):812-3. PubMed ID: 119120
    [No Abstract]   [Full Text] [Related]  

  • 25. [Time-dependency of serum carbamazepine concentration (author's transl)].
    Suzuki K; Kaneko S; Sato T
    No To Shinkei; 1978 Dec; 30(12):1293-302. PubMed ID: 104723
    [No Abstract]   [Full Text] [Related]  

  • 26. Risk factors for carbamazepine elevation and toxicity following epilepsy surgery.
    Hiremath GK; Kotagal P; Bingaman W; Hovinga C; Wyllie E; Morris H; Nelson D
    Seizure; 2005 Jul; 14(5):312-7. PubMed ID: 15876544
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Monotherapy with carbamazepine in childhood epilepsies].
    Dulac O; Bouguerra L; Rey E; de Lauture D; Arthuis M
    Arch Fr Pediatr; 1983 May; 40(5):415-9. PubMed ID: 6411042
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative drug monitoring of carbamazepin suspension (TroyaPharm) and Tegretol syrup (Ciba Geigy) in epileptic children.
    Peytchev L; Chakova L
    Folia Med (Plovdiv); 1998; 40(4):29-33. PubMed ID: 10371796
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Single evening administration of slow release carbamazepine].
    Stefan H; Schäfer H; Kuhnen C
    Nervenarzt; 1986 Jul; 57(7):405-7. PubMed ID: 3092119
    [No Abstract]   [Full Text] [Related]  

  • 30. [Preliminary report on the use of Tegretol sirup in epileptic patients].
    Monaco F; Riccio A; Furlan PM
    Riv Neurol; 1974 Mar; 44(2):123-33. PubMed ID: 4603758
    [No Abstract]   [Full Text] [Related]  

  • 31. Effect of plasma exchange on carbamazepine levels in a patient with myasthenia gravis and epilepsy.
    Siddiqi ZA; Holt A; Ahmed SN
    Epilepsia; 2005 Nov; 46(11):1841-2. PubMed ID: 16302866
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Carbamazepine plasma levels in children and adults: influence of age, dose, and associated therapy.
    Battino D; Bossi L; Croci D; Franceschetti S; Gomeni C; Moise A; Vitali A
    Ther Drug Monit; 1980; 2(4):315-22. PubMed ID: 7222185
    [No Abstract]   [Full Text] [Related]  

  • 33. [Diurnal fluctuations in plasma carbamazepine level in children with epilepsy].
    Losiowski Z; Prokopczyk J; Zimak J; Bielicka J
    Neurol Neurochir Pol; 1988; 22(3):195-200. PubMed ID: 3221956
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Variability of phenytoin, carbamazepine and valproate concentrations in a clinic population.
    Leppik IE
    Epilepsy Res Suppl; 1988; 1():85-90. PubMed ID: 3149581
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Is the therapy with carbamazepine more effective when measuring blood levels?
    Tatzer E; Groh C
    Padiatr Padol; 1980; 15(4):293-6. PubMed ID: 7007988
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CSF concentrations and serum protein binding of carbamazepine and carbamazepine-10,11-epoxide in epileptic patients.
    Johannessen SI; Gerna M; Bakke J; Strandjord RE; Morselli PL
    Br J Clin Pharmacol; 1976 Aug; 3(4):575-82. PubMed ID: 22216497
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Evaluation of the biological availability of 2 carbamazepine preparations].
    Niedzielska K; Rosnowska M; Kuran W
    Neurol Neurochir Pol; 1986; 20(5):415-20. PubMed ID: 3295573
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Clinicopharmacologic study of blood carbamazepine levels in a group of epileptic patients].
    Testa G; Ermani M; Giaretta D; Pellegrini A; Paleari C
    Riv Neurol; 1980; 50(4):241-52. PubMed ID: 7466220
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Predicting the range of plasma carbamazepine concentrations in patients with epilepsy.
    Racine-Poon A; Dubois JP
    Stat Med; 1989 Nov; 8(11):1327-37. PubMed ID: 2609045
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The use of phenobarbital and carbamazepine (finlepsin) in children with epilepsy and cerebral spastic palsy with epileptic syndrome].
    Gerasimiuk DL; Gusel' VA; Klimenko VA; Korovin AM
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1990; 90(8):25-7. PubMed ID: 2175112
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.